Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Compositions, organisms, systems, and methods for expressing a gene product in plants using SCBV expression control sequences operable in monocots and dicots
Cabinet door with tread pattern
Antitumoral compounds
Method and device for reliable estimation of network traffic
Control device with adjusting pulse width modulation function and the backlight module thereof
Sharing networks determined by sharing of items between individuals
Schottky diode and method of manufacture
  Randomly Featured Patents
Spread spectrum time diversity communications system
Methods and systems for providing a protecting tube
Process for chemical reaction of amino acids and amides yielding selective conversion products
Stove cover device
Ion source
Controller for a computer
Servicing a wellbore with an aqueous based fluid comprising a clay inhibitor
Joint filler
Clutch drum and method for manufacturing such clutch drum
Cleaner having improved dissolution time and clarity and improved of preparation